StockData
IQVIA Holdings Inc. logo

IQVIA Holdings Inc. (IQV) stock

IQVNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 9/3016% above fair value
$257.60−7.13 (-2.69%)

Close on Nov 17, 2026Market cap $42.45BP/E 31.3Yield –

Iqvia ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Iqvia's ebitda for the twelve months ending Sep 30, 2026 was $3.44B, up 3.8% year over year. For fiscal 2025 it was $3.33B, up 0.3% from the year before. Over ten years it grew 15.7% a year on average. The highest annual figure on record is $3.33B in fiscal 2025.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.33B+0.3%
FY2024Dec 31, 2024$3.32B+6.9%
FY2023Dec 31, 2023$3.10B+5.9%
FY2022Dec 31, 2022$2.93B+10.2%
FY2021Dec 31, 2021$2.66B+31.7%
FY2020Dec 31, 2020$2.02B+2.0%
FY2019Dec 31, 2019$1.98B+5.2%
FY2018Dec 31, 2018$1.88B+12.3%
FY2017Dec 31, 2017$1.68B+93.8%
FY2016Dec 31, 2016$865.00M+11.8%
FY2015Dec 31, 2015$774.00M+8.9%
FY2014Dec 31, 2014$711.00M+24.8%
FY2013Dec 31, 2013$569.84M+15.2%
FY2012Dec 31, 2012$494.72M+13.1%
FY2011Dec 31, 2011$437.26M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$893.00M+6.4%
Q2 FY2026Jun 30, 2026$798.00M+2.0%
Q1 FY2026Mar 31, 2026$802.00M+5.4%
Q4 FY2025Dec 31, 2025$944.00M+1.6%
Q3 FY2025Sep 30, 2025$839.00M+1.3%
Q2 FY2025Jun 30, 2025$782.00M-0.9%
Q1 FY2025Mar 31, 2025$761.00M-1.2%
Q4 FY2024Dec 31, 2024$929.00M+13.7%
Q3 FY2024Sep 30, 2024$828.00M+6.4%
Q2 FY2024Jun 30, 2024$789.00M+0.8%
Q1 FY2024Mar 31, 2024$770.00M+6.4%
Q4 FY2023Dec 31, 2023$817.00M+11.0%
Q3 FY2023Sep 30, 2023$778.00M+8.1%
Q2 FY2023Jun 30, 2023$783.00M+8.3%
Q1 FY2023Mar 31, 2023$724.00M-3.5%
Q4 FY2022Dec 31, 2022$736.00M+1.5%
Q3 FY2022Sep 30, 2022$720.00M+12.9%
Q2 FY2022Jun 30, 2022$723.00M+14.9%
Q1 FY2022Mar 31, 2022$750.00M+12.8%
Q4 FY2021Dec 31, 2021$725.00M+14.5%
Q3 FY2021Sep 30, 2021$638.00M+26.1%
Q2 FY2021Jun 30, 2021$629.00M+70.0%
Q1 FY2021Mar 31, 2021$665.00M+30.6%
Q4 FY2020Dec 31, 2020$633.00M+31.9%
Q3 FY2020Sep 30, 2020$506.00M+0.6%
Q2 FY2020Jun 30, 2020$370.00M-24.6%
Q1 FY2020Mar 31, 2020$509.00M+0.8%
Q4 FY2019Dec 31, 2019$480.00M-4.2%
Q3 FY2019Sep 30, 2019$503.00M+8.4%
Q2 FY2019Jun 30, 2019$491.00M+8.6%
Q1 FY2019Mar 31, 2019$505.00M+8.6%
Q4 FY2018Dec 31, 2018$501.00M+19.3%
Q3 FY2018Sep 30, 2018$464.00M+2.9%
Q2 FY2018Jun 30, 2018$452.00M+21.8%
Q1 FY2018Mar 31, 2018$465.00M+7.1%
Q4 FY2017Dec 31, 2017$420.00M+25.4%
Q3 FY2017Sep 30, 2017$451.00M–
Q2 FY2017Jun 30, 2017$371.00M–
Q1 FY2017Mar 31, 2017$434.00M–
Q4 FY2016Dec 31, 2016$335.00M–

More Iqvia figures

See a number that looks wrong?